Covid-19: Multidisciplinary Researches of Forensic and Pharmaceutical Risks and Causal Relationships of Unqualified Medical Care for Patients During Pandemic
DOI:
https://doi.org/10.53933/sspmlp.v2i1.39Keywords:
multidisciplinary research, forensic and pharmaceutical risks, causation, unqualified medical care, medical errors, COVID-19 pandemic, long-COVID, post-COVID, Estonian digital health care systemAbstract
A multidisciplinary study was conducted to study the forensic and pharmaceutical risks and to establish the casual relationships of unqualified medical care (medical errors) to patients and the development of diseases during the COVID-19 pandemic. It was substantiated that in the context of the coronavirus pandemic, multidisciplinary research in the field of healthcare combines interdisciplinary links of scientists from around the world in medicine, pharmacy, law, economics on good medical practice, pharmaceutical provision and availability of clinical and pharmacological, nomenclature and legal groups for all contingents of patients. It was noted in examples from forensic and pharmaceutical practice that unqualified medical care (medical or medical errors) can lead to varying degrees of severity of health disorders, improper performance of professional duties by a medical or pharmaceutical worker contains in its content forensic pharmaceutical risks provision of medicines, ultimately leads to health offenses. Causation has been shown to be associated with pandemics of coronavirus infection in the context of COVID, long-COVID and post-COVID health disorders. It was noted that the pandemic to COVID-19 and its consequences have three characteristic features of traumatic events: unpredictability, uncontrollability, threat of death or serious injury. The experience of the USA, France, Israel, China, EU countries on the example of Estonia on the organization of the healthcare system during the COVID-19 pandemic were studied. It was shown that the commercialization of the system of legal relations "doctor-patient-pharmacist-lawyer" affects the quality of medical practice and the availability of medicines for patients. Emphasis was placed on the continuing of professional development for healthcare professionals in the casual relationship of unqualified medical care (medical errors) to patients and the development of COVID, long-COVID and post-COVID diseases during the COVID-19 pandemic. The prospects of using Estonia's experience in the digital healthcare system, which covers all medical institutions in the country and every citizen were mentioned.
References
Shapovalova V.A., Zbrozhek S.I., Shapоvalov V.V. et al. Coronavirus disease pandemia 2019: growth of epidemic dangers. Acta scientific pharmaceutical sciences. 2020. Vol. 4. Iss. 7. P. 61–68. URL: https://www.actascientific.com/ASPS/ASPS-04-0559.php. DOI: https://doi.org/10.31080/ASPS.2020.04.0559
Shapovalov V. (Jr.), Zbrozhek S., Gudzenko A. et al. Organizational and legal analysis of the pharmaceutical provision for the most common diseases of society. International Journal of Pharmaceutical Sciences Review and Research. 2018. Vol. 51. N. 1. P. 118-124. URL: http://globalresearchonline.net/journalcontents/v51-1/18.pdf.
Chuiev Y., Shapovalova V. Interdisciplinary pharmacoeconomic study of pharmacotherapy of cupping of drunk forms of alcohol dependence: clinical and pharmacological, organizational, legal and marketing experiment. SSP Modern Pharmacy and Medicine. 2021. Vol. 1. N. 2. P. 1-12. URL: https://doi.org/10.53933/sspmpm.v1i2.24. DOI: https://doi.org/10.53933/sspmpm.v1i2.24
Zbrozgek S. Reform of the healthcare system as a basis for streamlining the organization of circulation and availability of medicines for patients in the context of the COVID-19 pandemic. SSP Modern Pharmacy and Medicine. 2021. Vol. 1. No. 2. P. 1-32. URL: https://doi.org/10.53933/sspmpm.v1i2.31. DOI: https://doi.org/10.53933/sspmpm.v1i2.31
Hayduchok І. Рharmacotherapy of systemic autoimmune diseases in conditions of the COVID-19 pandemic: innovative experimental study. Science Review. 2021. Vol. 3. No. 38. P. 1-7. DOI: 10.31435/rsglobal_sr/30072021/7619. DOI: https://doi.org/10.31435/rsglobal_sr/30072021/7619
Shapovalova V.A., Zbrozhek S.I., Shapovalov V.V. et al. Forensic pharmacy: some risk factors in the formation of addictive health disorders. Acta Scientific Pharmaceutical Science. 2021. V. 4. Iss. 1. P. 7-12. DOI: 10.3180/ASPS.2020.05.0651. DOI: https://doi.org/10.31080/ASPS.2020.05.0651
Shapovalova V.A., Zbrozhek S.I., Shapovalov V.V. (Jr.) et al. Forensic and pharmaceutical study of causal relationships between social and medical risk factors in the formation of addictive health disorders. Health of Society. 2020. Is. 9.No. 6. P. 236-242. DOI: https://doi.org/10.22141/2306-2436.9.6.2020.226954. DOI: https://doi.org/10.22141/2306-2436.9.6.2020.226954
Halatsan O.V., Shapovalova V.O., Shapovalov V.V. et al. Farmatsevtychne pravo v derzhavnii systemi minimizatsii sudovo-farmatsevtychnykh ryzykiv pry obihu likarskykh zasobiv u silskii mistsevosti. Ukr. visnyk psykhonvrolohii. 2013. T. 21, Vyp. 2 (75). – S. 96-100. URL: https://uvnpn.com.ua/sq.
Hayduchok I., Shapovalov V. Forensic Pharmacy and Medicine: Risks for Pharmacotherapy of Addiction and Countering of Illegal Circulation of Psychoactive Substances in the COVID-19 Pandemic. SSP Modern Pharmacy and Medicine. 1(2), 1–28. URL: https://doi.org/10.53933/sspmpm.v1i2.32. DOI: https://doi.org/10.53933/sspmpm.v1i2.32
Shapovalov V.V., Gudzenko A.A., Shapovalova V.A. et al. Forensic and pharmaceutical analysis of addictive morbidity because of the use of psychoactive substances in Ukraine. Klin.inform.telemed. 2020. Vol. 15. Iss. 16. P. 125-128. URL: https://doi.org/10.31071/kit2020.16.02. DOI: https://doi.org/10.31071/kit2020.16.02
Shapovalov V.V. Forensic and pharmaceutical study of abuse and developing the principles of reducing the demand for psychoactive substances of different classification and regulatory groups. Farmatsevtychnyi zhurnal. 2014. N. 2. P. 39-47.
Shapovalov V. (Jr.), Gudzenko A., Shapovalova V. at. el. Forensic and pharmaceutical study of the presence of a causal link between the degree of alcohol abuse and qualification level of the respondents. Pharmacia. 2017. Vol. 66. N. 3. R. 31–39. URL: http://bsphs.org/wp-content/uploads/2017/11/Shapovalov.pdf.
Shapovalov (mol.) V.V., Shapovalov V.V., Shapovalova V.O., Rohozhnikova O.V. Sudovo-farmatsevtychni ryzyky: nenalezhne vykonannia profesiinykh oboviazkiv medychnym abo farmatsevtychnym pratsivnykom, shcho zavazhaie zabezpechenniu likarskymy zasobamy pilhovoho kontynhentu na osnovi farmatsevtychnoho prava. Teoriia i praktyka pravoznavstva. 2014. No. 2(6). P. 1-19.
Shapovalov V.V. (Jr.), Shapovalova V.A., Shapovalov V.V. Development of forensic and pharmaceutical researches within the organization of pharmaceutical business, drug technology and pharmaceutical law in Ukraine concerning the turnover of controlled drugs and substances. Health of Society. 2021. Vol. 10. N. 3. P. 98-106. DOI: https://doi.org/10.22141/2306-2436.10.3.2021.246351. DOI: https://doi.org/10.22141/2306-2436.10.3.2021.246351
Shapovalova V.A., Shapovalov V.V., Shapovalov V.V. et al. Forensic and pharmaceutical assessment of polydrug addiction at combined use of psychoactive substances. Likarska sprava. 2018. N. 1-2 (1146). P. 171-177. DOI: 10.31640/JVD.1-2.2018(29). DOI: https://doi.org/10.31640/JVD.1-2.2018(29)
Vasina Yu.V., Shapovalov V.V., Shapovalova V. O., Kovalova K. I. Sudovo-farmatsevtychni aspekty porushen pravyl obihu psykhoaktyvnykh likarskykh zasobiv u zakladakh okhorony zdorovia. Ukr. visnyk psykhonevrolohii. 2015. T. 23, Vyp. 1 (82). S. 123-127. URL: https://uvnpn.com.ua/.
Shapovalov V.V., Shapovalov V.V. (Jr.), Shapovalova V.A. et al. The study of medicines with ephedrine circulation in the Russian Federation and in the Ukraine from the position of forensic pharmacy. Belgorod National Research University. 2017. No. 12 (261), Is. 38. P. 130-140. URL: http://dspace.bsu.edu.ru/handle/123456789/23850.
Shapovalov V. (Jr.), Gudzenko A., Komar L. at. el. Concerning the importance of forensic and pharmaceutical researches to improve patients accessibility to medicines. Pharmacia. 2017. Vol. 65. N. 2. P. 23–29. URL: http://bsphs.org/wp-content/uploads/2017/07/Shapovalov.pdf.
Shapovalov (Jr.) V., Gudzenko A., Shapovalova V.et al. Forensic and pharmaceutical analysis of addictive morbidity because of the use of narcotic psychoactive substances in Ukraine (retrospective aspect). International Journal of Pharmaceutical Sciences and Research. 2018. Vol. 3; Is. 3. P. 22-25. URL: http://www.pharmacyjournal.net/archives/2018/vol3/issue3.
Gudzenko A., Shapovalov V., Shapovalov V., Shapovalova V. Forensic pharmacy: analysis of complaints about the pharmaceutical provision for privileged categories of patients in Ukraine (experimental research). Science Review. 2021. V. 2. Iss. 37. P. 1–6. DOI: https://doi.org/10.31435/rsglbal_sr/30042021/7517.
Shapovalov V.V. (Jr.), Shapovalov V.V., Shapovalova V.A. et al. Forensic pharmacy in the state concept of combating drug addiction among the population of Ukraine and Russia to increase the availability of narcotic analgesics. Belgorod National Research University. 2015. T. 1. No. 1. P. 30-50. URL: http://dspace.bsu.edu.ru/handle/123456789/42659. DOI: https://doi.org/10.18413/2313-8955-2015-1-1-30-50
Criminal Code of Ukraine as amended and supplemented as of November 20, 2021. 2001. Verkovna Rada of Ukraine. URL: https://zakon.rada.gov.ua/laws/show/2341-14#Text.
COVID pandemic fuelling major increase in drug use worldwide: UN report. United Nations. URL: https://news.un.org/en/story/2021/06/1094672.
Operatyvna informatsiia pro poshyrennia ta profilaktyku COVID-19. MOZ Ukrainy. 31.10.2021. URL:https://moz.gov.ua/article/news/operativna-informacija-pro-poshirennja-koronavirusnoi-infekcii-2019-cov19.
Kuryshko D. Liashko: busterna doza bude z sichnia, a nova khvylia kovid – v kintsi zymy. BBC News Ukraine. 30.11.2021. URL: https://www.bbc.com/ukrainian/features-59473820.
Novyny Ukrainy: Viktor Liashko zaiavyv, shcho tretia busterna doza bude dostupna ne ranishe sichnia. TSN.UA. 01.12.2021. URL:https://tsn.ua/video/video-novini/novini-ukrayini-viktor-lyashko-zayaviv-scho-tretya-busterna-doza-bude-dostupna-ne-ranishe-sichnya.html.
WHO designates new COVID strain Omicron as ‘variant of concern. Gur Times. URL: https://gurtimes.com/business/who-designates-new-covid-strain-omicron-as-variant-of-concern/.
WHO designates new COVID strain Omicron as ‘variant of concern. Aljazeera. URL: https://www.aljazeera.com/news/2021/11/26/who-designates-new-covid-strain-omicron-variant-of-concern.
CDC Expands Eligibility for COVID-19 Booster Shots to All Adults. CDC. 19.11.2021. URL:https://www.cdc.gov/media/releases/2021/s1119-booster-shots.html.
Comirnaty and Spikevax: EMA recommendations on extra doses and boosters. EMA. 10.04.2021. URL:https://www.ema.europa.eu/en/news/comirnaty-spikevax-ema-recommendations-extra-doses-boosters.
Duqueroy V. Should Everyone Get a COVID-19 Vaccine Booster? Medscape. November 25, 2021. URL:https://www.medscape.com/viewarticle/963683.
Busterne shcheplennia: chomu vono duzhe vazhlyve, popry te, shcho vaktsynovanyi Izrail prodovzhuie khvority. TSN.UA. 03.12.2021. URL: https://tsn.ua/svit/busterne-scheplennya-chomu-vono-duzhe-vazhlive-popri-te-scho-vakcinovaniy-izrayil-prodovzhuye-hvoriti-1922848.html.
Omicron Spreading in U.S.; Gilead Recalls Vials: Virus Update. Bloomberg News. 03.12.2021. URL:https://www.bloomberg.com/news/articles/2021-12-03/omicron-in-eight-u-s-states-south-africa-surges-virus-update.
«Third dose of the vaccine is extremely efficient» Israeli study: COVID booster shots 92% effective at preventing serious illness. The Times of Israel. 30.10.2021. URL: https://www.timesofisrael.com/israeli-study-covid-booster-shots-92-effective-at-preventing-serious-illness/.
Barda N., Dagan N., Cohen C. et. al. Effectiveness of a third dose of the bnt162b2 mrna COVID-19 vaccine for preventing severe outcomes in Israel: an observational stugy. The Lancet. 04.12.2021. Vol. 398. Iss. 10316. Р. 2093-2100. URL:https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02249-2/fulltext. DOI: https://doi.org/10.1016/S0140-6736(21)02249-2
Barbash G. Half of serious COVID-19 cases fully vaccinated. Arutz Sheva. 08.07.2021. URL:https://www.israelnationalnews.com/News/News.aspx/309494.
Song W. China’s global engagement to fight the novel coronavirus pandemic. Global Health Research and Policy. 2020. Vol. 5. N. 44. URL:https://ghrp.biomedcentral.com/articles/10.1186/s41256-020-00172-1/. DOI: https://doi.org/10.1186/s41256-020-00172-1
Qiu J., Shen B., Zhao M. et al. A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations. Gen Psychiatry. 2020. URL:https://doi.org/10.1136/gpsych-2020-100213. DOI: https://doi.org/10.1136/gpsych-2020-100213
Li H., Hu M., Liu S. The need to improve the laws and regulations relevant to the outbreak of COVID-19: what might be learned from China? Viewpoints. 2020. N. 10 (1). P. 1–4. URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182299/. DOI: https://doi.org/10.7189/jogh.10.010328
Tian H., Liu Y., Li Y. et al. An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China. Science. 2020. Vol. 368. N. 6491. P. 638–642. URL:https://pubmed.ncbi.nlm.nih.gov/32234804/. DOI: https://doi.org/10.1126/science.abb6105
Wang Y., Pan X., Baі Y. The Experience of рatients with COVID-19 in China: аn іnterpretative рhenomenological аnalysis. PRBM. 28.06.2021.Vol.2021. N.14. Р. 877-887.DOI: https://doi.org/10.2147/PRBM.S310266. DOI: https://doi.org/10.2147/PRBM.S310266
VOOZ nazvala «duzhe vysokym» zahalnyi hlobalnyi ryzyk vid novoho shtamu koronavirusu. Radio Svoboda. 30.11.2021. URL: https://www.radiosvoboda.org/a/news-omikron-vooz-ryzyky/31586271.html.
Bratushchyk-Khoma M. Duzhe vysokyi ryzyk spleskiv: u yakykh krainakh vyiavyly Omicron ta chy efektyvni vid noho vaktsyny. Ukr. tyzhden. 30.11.2021. URL: https://tyzhden.ua/Pandemic/253756.
Kuznetsova I. Pro oboviazkovu vaktsynatsiiu, tretiu dozu, COVID-shakhraistvo i zarplaty medykiv. Interviu ministra Liashka. Radio Svoboda. 16.10.2021. URL: https://www.radiosvoboda.org/a/intervyu-z-ministrom-okhorony-zdorovya-viktorom-lyashkom/31509945.html.
VOOZ nazvala «duzhe vysokym» zahalnyi hlobalnyi ryzyk vid novoho shtamu koronavirusu. Radio Svoboda. 30.11.2021. URL: https://www.radiosvoboda.org/a/news-omikron-vooz-ryzyky/31586271.html.
Voronenko Yu.V. Bezperervnyi profesiinyi rozvytok likariv ta provizoriv v umovakh reformuvannia systemy okhorony zdorovia (9 zhovtnia 2020 roku). MOZ Ukrainy, Natsionalna medychna akademiia pisliadyplomnoi osvity imeni P. L. Shupyka. Kyiv. 2020. S. 24-25 URL: https://nmapo.edu.ua/zagruzka2/CPD_conference_NMAPO_2020.
Shapovalov V. V., Shapovalov V. V., Shapovalova V. A., Omelchenko V. O. Vyvchennia mizhdystsyplinarnykh zviazkiv kryminalno-pravovykh ta sudovo-farmatsevtychnykh norm u systemi obihu likarskykh zasobiv. Teoriia i praktyka pravoznavstva. 2017. Vyp. 1 (11). 9s. URL: https://dspace.nlu.edu.ua/bitstream/123456789/16367/1/11.
Shapovalov Valentyn V., Shapovalov V.V., Shapovalova V.O., Kulikova O.V. Orhanizatsiia zabezpechennia antypsykhotychnymy likarskymy zasobamy na zasadakh farmatsevtychnoho prava i sudovoi farmatsii. Ukr. visnyk psykhonvrolohii. 2016. T. 24. Vyp. 1 (86). S. 138-144. URL: http://www.psychiatry.ua/uvp/.
Shapovalov V.V., Shapovalov V.V. (ml.), Shapovalova V.A. Farmatsevtycheskoe y medytsynskoe pravo: uch. posob. (seryia: Farmatsevtycheskoe pravo). [1-e yzd.]. Kh.: Yzd-vo «Skorpyon», 2011. 208 s.
Radionova V.A., Shapovalov V.V. (ml.), Shapovalova V.A. et al. Sudebno-farmatsevtycheskoe yzuchenye problemy zhenskoi narkomanii: prichinno-sledstvennie sviazi oborota psykhoaktivnykh veshchestv, zabolevaemosty u narkoprestupnosti. Belgorod National Research University. 2015. No. 4 (201). V. 29. S.124–130. URL: https://www.bsu.edu.ru/bsu/science/public/bsu-sciencejournal/detail.php?IBLOCK_ID=106&SECTION_ID=572&ELEMENT_ID=326706.
Shapovalov V.V. (Jr.), Shapovalova V.A., Shapovalov V.V. et al. Forensic and pharmaceutical status of the determination of depending from cannabinoids (F12). European Applied Sciences. 2013. Vol. 2. N. 9. P. 146-149.
Shapovalov (Jr.) V.V., Shapovalova V.V., Shapovalov V.V. et al. Comparative analysis of availability of the medicines for privileged categories of citizens suffering from diabetes mellitus in the Russian Federation and Ukraine based on the pharmaceutical law. Annals of Mechnikov institute. 2015. N. 1. P. 14-20. URL: http://nbuv.gov.ua/jpdf/ami_2015_1_4.pdf.
Shapovalova V.O., Shapovalov V.V., Osyntseva A.O. Vyznachennia dostupnosti likarskykh zasobiv dlia farmakoterapii alkoholnoi ta pyvnoi adyktsii z pozytsii farmatsevtychnoho i medychnoho prava ta sudovoi farmatsii. Klinichna farmatsiia, farmakoterapiia ta medychna standartyzatsiia. 2014. No. 3-4. S. 39–46.
Shapovalova V.O., Vasina Yu.V., Shapovalov V.V. Vyvchennia systemy obihu ekstemporalnykh likarskykh zasobiv v Ukraini na zasadakh farmatsevtychnoho prava Farmatsevtychnyi zhurnal. 2016. No. 1. S.77-85 URL: http://nbuv.gov.ua/UJRN/pharmazh_2016_1_15.
Shapovalov V.V., Shapovalova V.A., Shapovalov (Jr.) et al. The problem of turnover of the psychoactive substance alcohol: abuse, consequences, countermeasures. Research result. 2014. Vol. 1. N.2 (2). P. 45–51. URL: http://www.belsu-research-result.ru/images/issue2/pharmacy/pharmacy.pdf. DOI: https://doi.org/10.18413/2313-8955-2014-1-2-45-51
Shapovalov V.V. (ml.), Shapovalov V.V. Shapovalova V.A. et al. Sravnitelnyi analyz orhanyzatsyy farmatsevtycheskoi pomoshchi v Rossii, Ukraine y Belorussii v obespechenii lhotnykh katehoriy naselenyia. Belgorod National Research University. 2015. No. 10 (207). V. 30. S. 226-238. URL: http://dspace.bsu.edu.ru/handle/123456789/23850.
Shapovalov V.V. (ml.), Shapovalova V.A. Shapovalova V.V. et al. Izuchenie osobennostei oborota lekarstvennykh sredstv s efedrinom v Rossii i Ukraine s pozitsii sudebnoi farmatsii. Belgorod National Research University. 2015. No. 22 (219). V. 32. S. 175-180. URL: http://dspace.bsu.edu.ru/handle/123456789/23850.
Shapovalov V.V. (Jr.), Zbrozhek S.I., Shapovalova V.O. et al. Organizational and legal evaluation of availability of medicines circulation for cancer patients. Pharmacia. 2018. Vol. 65. N. 2. P. 17-22. URL: http://bsphs.org/?magasine=organizational-and-legal-evaluation-of-availability-of-medicines-circulation-for-cancer-patients.
Shapovalov V.V. (Jr.), Shapovalova V.A., Shapovalov V.V. Forensic and pharmaceutical research on the impact of drugs on the safety, life and health of road users within the organization of pharmaceutical business, drug technology, pharmaceutical and medical law in Ukraine. Health of Society. 2021. Vol. 10. N. 4. R. 127-132. DOI: https://doi.org/10.22141/2306-2436.10.4.2021.246355. DOI: https://doi.org/10.22141/2306-2436.10.4.2021.246355
Shapovalova V.A., Shapovalov V.V., Riazantseva N.N. et al. Kliniko-farmatsevticheskaya bezopasnost bezretsepturnykh protyvoiazvennykh lekarstvennykh sredstv s pozytsii dokazatelnoi meditsini i farmatsii. Farmatsyia Kazakhstana. 2015. No. 1 (164). S. 32-39. URL: https://www.ndda.kz/upload/dari.kz/Zhurnal/pharm_01_2015sait.
Shapovalov V.V., Shapovalova V.O. Modern state support drug patients in rural areas: analysis of complaints of citizens on principles of medical and pharmaceutical law. E-Journal: Research Bulletin SWorld «Modern scientific research and their practical application». 2013. R.93-96. URL: https://www.elibrary.ru/item.asp?id=28873229.
Petrenko V.O., Shapovalova V.O., Shapovalov V.V. Sudova farmatsiia: vyvchennia osoblyvostei zlovzhyvannia psykhoaktyvnymy rechovynamy riznykh klasyfikatsiino-pravovykh hrup sered zhinok. UVP. 2010. T. 18. Vyp. 4 (65). S. 98-100. URL: https://uvnpn.com.ua/.
Shapovalova V., Shapovalov V., Shapovalov V. et al. Experience of the department of medical and pharmaceutical law, general and clinical pharmacy of the Kharkiv medical academy of postgraduate education concerning the educational process during the quarantine period caused by COVID-19. Actual Problems of Medicine and Pharmacy. 2021. Vol. 2. N. 2. P. 1–20. URL: https://doi.org/10.52914/apmp.v2i2.33. DOI: https://doi.org/10.52914/apmp.v2i2.33
Shapovalova V.A., Sosin Y.K., Shapovalova V.V. et al. Farmatsevtycheskoe pravo v narkolohyy. Kharkov: Fakt, 2004. 800 s.
Hubskyi Yu.I., Shapovalova V.A., Kutko I.I. et al. Lekarstvennie sredstva v psykhofarmakologii. K.: “Zdorovia”, Kharkov: “Torsing”. 1997. 288 s.
Shapovalova V.A., Danylenko V.S., Shevchenko S.Y. et al. Lekarstvennie sredstva v klinicheskoi khirurgii. Kh.: “Torsing”. 1998. 605 s.
Shapovalova V.A., Shapovalov V.V. Spravochnyk po pravovoi y sudebnoi farmatsyy. Kharkov: «Torsynh». 1997. 656 s.
Shapovalova V.A., Danylenko V.S., Shapovalov V.V. et al. Lekarstvennie sredstva, otpuskaemye bez retsepta vracha. Kharkov: “Torsing”. 1988. 528 s.
Shapovalova V.A., Shapovalov V.V., Vyrva E.E. et al. Farmatsevticheskoe pravo v ginekologii. Kharkov: Fakt. 288 s.
Shapovalova V.O., Shapovalov V.V. Pytannia normatyvnoho tlumachennia i klasyfikatsii likarskykh zasobiv yak skladovoi chastyny u haluzi pravovoho rehuliuvannia obihu sylnodiiuchykh, otruinykh i psykhotropnykh rechovyn, narkotychnykh zasobiv i prekursoriv v Ukraini. Farmakol. Visnyk. 1998. No. 4. S. 19-24.
Shapovalov V.V. (ml.), Ryshchenko O.A., Shapovalov V.V. et al. Meditsynskoe i farmatsevticheskoe pravo: analiz kliniko-farmakolohicheskikh hrupp lekarstvennykh sredstv, primeniaemykh v farmakoterapii kardiologicheskikh zabolevaniy v ramkakh formuliarnoi systemy Rossii i Ukrainy. Belgorod National Research University. 2014. No. 24 (195). V. 28. S.137-143. URL: https://www.bsu.edu.ru/bsu/science/public/bsu-science-journal/list.php?SECTION_ID=572.
Ryshchenko O.O., Shapovalov V.V., Shapovalova V.O. et al. Sudovo-farmatsevtychne doslidzhennia rehionalnoho rivnia zabezpechennia likarskymy zasobamy patsiientiv z neiroendokrynnymy onkolohichnymy zakhvoriuvanniamy na osnovi medychnoho ta farmatsevtychnoho prava. Farmakom. 2014. No. 3. S. 56-62. URL: http://sphu.org/wp-content/uploads/2017/01/Farmacom_3_2014.pdf.
Shapovalov V.V. (ml.), Shapovalov V.V., Omelchenko V.A. et al. Farmatsevticheskoe pravo: neobkhodimost povyshenyia urovnia informirovaniya vrachei i provizorov o pravilakh oborota narkotycheskikh i psikhotropnykh lekarstvennykh sredstv (sudebno-farmatsevticheskie aspekty). Vestnyk Tadzhykskogo natsionalnogo universiteta. 2013. No. 3 (4). S. 135–140.
Shapovalov Valentyn V., Shapovalov V.V., Shapovalova V.O. et al. Sudovo-farmatsevtychni ryzyky: nenalezhne vykonannia profesiinykh oboviazkiv medychnym abo farmatsevtychnym pratsivnykom, shcho zavazhaie zabezpechenniu likarskymy zasobamy pilhovoho kontynhentu na osnovi farmatsevtychnoho prava. Teoriia i praktyka pravoznavstva. 2014. V. 2 (6). URL: http://tlaw.nlu.edu.ua/article/view/63579.
Shapovalov V.V., Shapovalova V.A., Petrenko S.L. Ispolzovanie rezultatov operativno-rozysknoi deiatelnosty otdelov po borbe s narkotikami v protsesse prepodavanyia predmeta «Pravovaia i sudebnaia farmatsiia» dlia ukreplenyia natsyonalnoi bezopasnosty. Zb. nauk. prats: “Aktualni problemy medychnoi nauky”. Kh.: «Oko». 1998. S. 323–327.
Shapovalova V.A., Zabolotnyi V.A., Depeshko Y.T. et al. Farmatsevticheskiy analiz lekarstvennykh sredstv. Kharkov: YMP “Rubykon”. 1995. 400 s.
Haiduchok I.H., Shapovalova V.O., Shapovalov Val. V. et al. Rezhym kontroliu antybakterialnykh likarskykh zasobiv dlia farmakoterapii koronavirusnoi khvoroby (COVID-19) u patsiientiv z dualnymy rozladamy: informatsiinyi lyst pro novovvedennia. Ukrmedpatentinform MOZ Ukrainy. K.: Ukrmedpatentinform MOZ Ukrainy. 2020. N. 230-2020. 6 s.
Hayduchok I. Pharmacotherapy of systemic vasculitis combined with cryoglobulinemic syndrome using pharmacoeconomic approaches. Global Journal of Health Science. 2021. Vol. 13. N. 7. P. 78-88. URL: https://doi.org/10.5539/gjhs.v13n7p78. DOI: https://doi.org/10.5539/gjhs.v13n7p78
Roberts M. What are the Delta, Gamma, Beta and Alpha Covid variants? BBC News. URL: https://www.bbc.com/news/health-55659820.
Callaway E. Heavily mutated coronavirus variant puts scientists on alert. Nature. 25.11.2021. URL:https://www.nature.com/articles/d41586-021-03552-w.
Naidoo R., Cele S. New Coronavirus Variant a ‘Serious Concern in South Africa. Bloomberg. URL: https://www.bloomberg.com/news/articles/2021-11-25/who-meets-on-new-covid-19-variant-circulating-in-south-africa
Hayduchok I.G. Innovation approaches to pharmacotherapy of systemic autoimmune diseases in the conditions of the COVID-19 pandemic. Likarska Sprava. 2020. N. 7-8. P. 64-74. DOI: 10.31640/JVD.7-8.2020 (8). DOI: https://doi.org/10.31640/JVD.7-8.2020(8)
Hayduchok I. Supportive pharmacotherapy for systemic autoimmune diseases with hyperimmunocomplex syndrome (experimental research). Georgian medical news. 2021. N. 9 (318). P. 159-165.
Hayduchok I. Pharmacotherapy of systemic autoimmune diseases in the sonvention of the COVID-19 pandemic: search for innovative technologies in the study. Acta Scientific Medical Science. 2021. Vol. 5. Iss. 9. P. 136-142. DOI: 10.31080/ASMS.2020.05.1022. DOI: https://doi.org/10.31080/ASMS.2020.05.1022
Hayduchok I. Pharmacotherapy of psoriasis support with antiphospholipid syndrome: ABC/VEN – analysis of anti-viral drugs. SSP Modern Pharmacy and Medicine. 2021. Vol. 1. Iss. 1. P. 1-12. DOI: https://doi.org/10.53933/sspmpm.v1i1.4. DOI: https://doi.org/10.53933/sspmpm.v1i1.4
Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern. WHO. 26.11.2021. URL: https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern/.
Tukhar I., Shapovalova V., Shapovalov V. et al. Pharmacological view on the problem of comorbidity in the pharmacotherapy of chronic pancreatitis. Science Review. Vol.3. N.38. P.1-5. DOI: 10.31435/rsglobal_sr/30072021/7591. DOI: https://doi.org/10.31435/rsglobal_sr/30072021/7591
Tanno L.K., Chalmers R., Jacob R. at el. Global implementation of the World Health Organizations International Classification of Diseases (ICD)-11: The allergic and hypersensitivity conditions model. Allergy. 2020. N.75(9). R. 2206-2218. DOI: 10.1111/all.14468. URL: https://pubmed.ncbi.nlm.nih.gov/32578235/. DOI: https://doi.org/10.1111/all.14468
Poshchady ne chekaite: Venediktova oholosyla viinu pidrobnym kovid-sertyfikatam. BBC news Ukraina. 23.10.2021. URL: https://www.bbc.com/ukrainian/news-59021302.
Jonathan Jarry M.Sc. Medical error is not the third leading cause of death?. McGill. 27.08.2021. URL: https://www.mcgill.ca/oss/article/critical-thinking-health/medical-error-not-third-leading-cause-death.
Saks M. J., Landsman S. Use systems redesign and the law to prevent medical errors and accidents. Stat. 04.08.2021. URL: https://www.statnews.com/2021/08/04/medical-errors-accidents-ongoing-preventable-health-threat/.
Makary M. A, Daniel M. Medical error – the third leading cause of death in the US. BMJ. 2016. N. 353. DOI: https://doi.org/10.1136/bmj.i2139. DOI: https://doi.org/10.1136/bmj.i2139
Postanova MOZ Ukrainy vid 09.05.2020 No. 19 “Pro zatverdzhennia tymchasovykh rekomendatsii shchodo orhanizatsii protyepidemichnykh zakhodiv pry nadanni stomatolohichnoi dopomohy na period karantynu u zviazku z poshyrenniam koronavirusnoi khvoroby (COVID-19)”. Verkhovna Rada Ukrainy. 09.05.2020. URL: https://zakon.rada.gov.ua/rada/show/v0019488-20#Text.
Sprava rivnenskoi stomatolohyni pishla do sudu. Bykvu.com. 11.03.2021. URL: https://bykvu.com/ua/bukvy/sprava-rivnenskoi-stomatologini-pishla-do-sudu/.
U Rivnomu pereviriaiut stomatoloha cherez travmy u ditei. Ukrainska pravda. 12.02.2021. URL: https://www.pravda.com.ua/news/2021/02/12/7283276/.
Viddil komunikatsii politsii Rivnenskoi oblasti. Kryminalne provadzhennia shchodo rivnenskoi stomatolohyni skeruvaly do sudu. MVS.gov.ua. 11.03.2021. URL:https://mvs.gov.ua/ua/news/39624_Kriminalne_provadzhennya_shchodo_rivnenskoi_stomatologini_skeruvali_do_sudu.htm.
V Zhytomyre vrach pыtalsia ubyt dyrektora stomatolohycheskoho tsentra. Ukrayna Krymynalnaia. 27.11.2020. URL: https://cripo.com.ua/news/crime/v-zhitomire-vrach-pytalsya-ubit-direktora-stomatologicheskogo-tsentra/.
Vstromyv nozhytsi v oko: na Zhytomyrshchyni pidlehlyi namahavsia vbyty dyrektorku stomatolohichnoho tsentru. NV. 30.11.2020. URL: https://nnovosti.info/news/vstromiv_nozhitsi_v_oko_na_zhitomirschini_pidleglij_namagavsja_vbiti_direktorku_stomatologichnogo_tsentru_foto-55919.html.
Smert 2-letneho malыsha v kabynete stomatoloha: pochemu sud v Maryupole opravdal vracha. Fakty Ukraina. 31.07.2021. URL: https://crime.fakty.ua/ru/381784-smert-2-letnego-malysha-v-kabinete-stomatologa-pochemu-sud-v-mariupole-opravdal-vracha.
Na Mukachivshchyni zatrymaly stomatoloha, yakyi prodavav amfetamin. Mukachevo.net. 18.10.2018. URL: http://www.mukachevo.net/ua/news/view/369220.
Stomatolohu z Mukachivshchyny, yakyi prodavav narkotyky, oholosyly pidozru. Mukachevo.net. 19.10.2018. URL: http://www.mukachevo.net/ua/news/view/369238.
Woods R. Why did Rachel Johnston die after having all her teeth removed? BBC News. 14.12.2018. URL: https://www.bbc.com/news/uk-england-hereford-worcester-46522258.
When does malpractice become a criminal act? ReliasMedia. 01.08.2020. URL: https://www.reliasmedia.com/articles/46678-when-does-malpractice-become-a-criminal-act.
Wang L., Wang F., Gershwin M. Human autoimmune diseases: a comprehensive update. Journal of Internal Medicine. 2015. Vol. 278. N. 4. P. 369–395. DOI: 10.1111/joim.12395. URL: https://onlinelibrary.wiley.com/doi/full/10.1111/joim.12395. DOI: https://doi.org/10.1111/joim.12395
Hoffman M. What are autoimmune disorders? WebMD. 2020. URL: https://www.webmd.com/a-to-z-guides/autoimmune-diseases.
Charangowda B. Dental records: an overview. J. Forensic Dent. Sci. 2010. Vol.2. N.1. P.5-10. DOI: 10.4103/0974-2948.71050. DOI: https://doi.org/10.4103/0974-2948.71050
General Dental Council. Standards for the dental team. 2013. 11 r. URL: https://standards.gdc-uk.org/Assets/pdf/Standards%20for%20the%20Dental%20Team.pdf.
Data and statistics. WHO euro. 24.19.2021. URL: https://www.euro.who.int/en/health-topics/Health-systems/patient-safety/data-and-statistics.
McGill L. Patient safety: a European Union priority. Clin Med (Lond). 2009. Vol. 9. N.2. R. 136-139. DOI: 10.7861/clinmedicine.9-2-136. URL: https://pubmed.ncbi.nlm.nih.gov/19435118/. DOI: https://doi.org/10.7861/clinmedicine.9-2-136
Politicians postpone discussion of decriminalization of medical errors. BNN. 27.11.2019. URL: https://bnn-news.com/politicians-postpone-discussion-of-decriminalization-of-medical-errors-207820.
Fuchsberg A. When Do Doctor Errors Become Criminal Medical Negligence? Fuchsberg. 2016. URL: https://www.fuchsberg.com/blog/medical-errors-become-criminal-negligence.
Robson M., Maskill J., Brookbanks W. Doctors Are Aggrieved—Should They Be? Gross Negligence Manslaughter and the Culpable Doctor. The Journal of Criminal Law. 17.08.2020. URL: https://journals.sagepub.com/doi/full/10.1177/0022018320946498. DOI: https://doi.org/10.1177/0022018320946498
Pandit M.S. Medical negligence: criminal prosecution of medical professionals, importance of medical evidence: some guidelines for medical practitioners. 2009. Indian J. Urol. Vol. 25. N. 3. R. 379–383. DOI: 10.4103/0970-1591.56207. URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779964/. DOI: https://doi.org/10.4103/0970-1591.56207
Shapovalov V.V. Sudova farmatsiia: yurydychna opika spetsialistiv farmatsii i medytsyny u sferi protydii narkomanii i nezakonnomu obihu psykhoaktyvnykh rechovyn. Ukrainskyi visnyk psykhonevrolohii. 2011. T. 19. V. 1. S. 115–119. DOI: https://doi.org/10.1080/09672559.2011.547090
Shapovalov V.V. Yurydychna opika v systemi pravovidnosyn «likar – patsiient – provizor» na zasadakh medychnoho i farmatsevtychnoho prava. Upravlinnia zakladom okhorony zdorovia. 2012. No. 9. S. 29-37
Shapovalov V.V., Sosin I.K., Kapielnikova Ye.V.. Avtorske pravo 59560, Ukraina. Yurydychna opika v systemi pravovidnosyn «likar» – «narkokhvoryi» – «provizor» u prohramakh zamisnoi pidtrymuvalnoi terapii v Ukraini. No. 59997. Zaiavl. 10.03.15. Opubl. 07.05.15.
Babkina O.P., Varukha K.V. Do pytannia pro zapobihannia prytiahnennia farmatsevtychnykh pratsivnykiv do kryminalnoi vidpovidalnosti. Kh.: Vyd-vo NFaU. 2015. S. 25-26.
Diadyk O.D., Zaritska V.K., Beketova Yu K. ta in. Osoblyvosti bezperervnoho profesiinoho rozvytku likariv patolohoanatomiv v umovakh reformuvannia medytsyny ta pandemii Covid-19 // Bezperervnyi profesiinyi rozvytok likariv ta provizoriv v umovakh reformuvannia systemy okhorony zdorovia (9 zhovtnia 2020 roku). MOZ Ukrainy, Natsionalna medychna akademiia pisliadyplomnoi osvity imeni P. L. Shupyka. Kyiv: NMAPO imeni P. L. Shupyka, 2020. S. 125-127. URL: https://nmapo.edu.ua/zagruzka2/CPD_conference_NMAPO_2020.
Barchuk O., Zaliska O., Maksymovych N. Priorytety bezperervnoho profesiinoho rozvytku provizoriv v umovakh pandemi Covid-19 ta reformuvannia systemy okhorony zdorovia Ukrainy. Kyiv: NMAPO imeni P.L. Shupyka, 2020. S. 127-128 URL: https://nmapo.edu.ua/zagruzka2/CPD_conference_NMAPO_2020.
Bida V. D., Doroshenko O. D., Radko V. K. ta in. Orhanizatsiia bezperervnoho profesiinoho rozvytku likariv stomatolohiv–ortopediv na kafedri ortopedychnii stomatolohii. Kyiv, NMAPO imeni P.L. Shupyka. 2020. S. 152-158. URL: https://nmapo.edu.ua/zagruzka2/CPD_conference_NMAPO_2020.
Mintser O., Babintseva L. Hlobalni zminy pedahohichnoi stratehii peredavannia znan pry bezperervnomu profesiinomu rozvytku likariv i provizoriv v umovakh pandemii. Kyiv: NMAPO imeni P.L. Shupyka, 2020. S. 33-37 URL: https://nmapo.edu.ua/zagruzka2/CPD_conference_NMAPO_2020.
Likari zmozhut pidvyshchuvaty kvalifikatsiiu zavdiaky profesiinomu medychnomu stazhuvanniu. MOZ Ukrainy. 15.11.2021. URL: https://moz.gov.ua/article/news/likari-zmozhut-pidvischuvati-kvalifikaciju-zavdjaki-profesijnomu-medichnomu-stazhuvannju.
Everything you need to know about the Estonian eHealth reform. M-Health Conference Tallinn. 27.03.2019. URL: https://tallinn.mhealth.events/en/article/vsyo-o-tsifrovoy-meditsinskoy-reforme-v-estonii-97210.
Serdiuk V. Zvernennia prezydenta Vseukrainskoi Rady zakhystu prav ta bezpeky patsiientiv. Sait Lvivskoho medychnoho instytutu. 26.10.2021. URL: https://medinstytut.lviv.ua/zvernennya-viktora-serdyuka/.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Ihor Hayduchok, Valerii Shapovalov
This work is licensed under a Creative Commons Attribution 4.0 International License.
